Target intelligence / Profile preview

NPAS2 antisense RNA 1 (NPAS2-AS1)

Target
NPAS2-AS1
Molecular classification
Antisense non-coding RNA
01

Overview

NPAS2 antisense RNA 1 (NPAS2-AS1) is presumed to be an antisense non-coding RNA transcript complementary to the NPAS2 gene locus. There is currently no peer-reviewed functional data, molecular characterization, or recognition in gene/protein/ncRNA nomenclature authorities supporting an established role for NPAS2-AS1 in physiology, disease, or as a therapeutic target. All available research and annotation focus instead on the NPAS2 protein itself—a basic helix-loop-helix-PAS domain transcription factor crucial for circadian rhythm regulation and with emerging roles in cancer biology, metabolism, and neurobehavioral processes[2][5][6]. No data are available regarding the biological functions, disease associations, or druggability of the NPAS2-AS1 transcript. Clarification: If you are seeking information on "NPAS2," the canonical circadian transcription factor, detailed annotations are available and supported by the literature[2][5][6]. If you specifically require antisense RNA annotations, this transcript would be considered noncanonical, and there is insufficient information for any structured drug-target analysis.

Beyond the preview

Go deeper on NPAS2 antisense RNA 1 (NPAS2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NPAS2 antisense RNA 1 (NPAS2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call